Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data | The Journal of Headache and Pain | Full Text

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data | The Journal of Headache and Pain | Full Text

Sustained response to onabotulinumtoxin A in patients with chronic migraine: real-life data

Treatment with onabotulinumtoxin A (BT-A) is safe and effective for chronic migraine (CM). Several studies assessed possible predictors of response to treatment with BT-A, but there is little knowledge on the ...

Authors:Raffaele Ornello, Simona Guerzoni, Carlo Baraldi, Luana Evangelista, Ilaria Frattale, Carmine Marini, Cindy Tiseo, Francesca Pistoia and Simona Sacco

Citation:The Journal of Headache and Pain 2020 21:40

Content type:Research article

Published on: 25 April 2020

• ViewFull Text
 
• ViewPDF